Literature DB >> 14698506

Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism.

Ruxue Zhang1, Jinhuang Zhou, Zhengping Jia, Yongxiang Zhang, Guoming Gu.   

Abstract

The hypoglycemic and anti-diabetic effect of Rehmannia glutinosa oligosaccharide (ROS) in glucose-induced hyperglycemic and alloxan-induced diabetic rats and its mechanism was investigated in this paper. It was found that pretreatment of ROS in normal rats with 100 mg/kg for 3 days, i.p., induced a partial prevention of hyperglycemia caused by glucose (2g/kg, i.p.), while when hyperglycemia was induced in adrenalectomized (ADX) rats, the preventive effect of ROS on hyperglycemia was lost. In alloxan-induced diabetic rats, ROS (100 mg/kg for 15 days, i.p.) showed a significant decrease in blood glucose level and hepatic glucose-6-phosphatase activity with an increase in hepatic glycogen content. Furthermore, ROS raised plasma insulin level and lowered plasma corticosterone level in alloxan-induced diabetic rats. The results indicated that oligosaccharide of Rehmannia glutinosa Libosch. exerted a significant hypoglycemic effect in normal and alloxan-induced diabetic rats. The regulatory mechanism of ROS on glucose metabolism was adrenal dependent and had a close relation with the neuroendocrine system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698506     DOI: 10.1016/j.jep.2003.09.018

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  25 in total

Review 1.  Alginate lyase: Review of major sources and classification, properties, structure-function analysis and applications.

Authors:  Benwei Zhu; Heng Yin
Journal:  Bioengineered       Date:  2015-04-01       Impact factor: 3.269

2.  The glucose-induced synthesis of insulin in liver.

Authors:  Rajeshwary Ghosh; Soumendra K Karmohapatra; Gorachand Bhattacharya; A Kumar Sinha
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells.

Authors:  Jane C-J Chao; Shih-Wen Chiang; Ching-Chiung Wang; Ya-Hui Tsai; Ming-Shun Wu
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  Evaluation of hypoglycemic activity of the polysaccharides extracted from Lycium barbarum.

Authors:  Longjun Jing; Guowen Cui; Qiang Feng; Yuanshi Xiao
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-07-03

5.  Ameliorative effects of Cnidoscolus aconitifolius on alloxan toxicity in Wistar rats.

Authors:  O I Azeez; A A Oyagbemi; M O Oyeyemi; A A Odetola
Journal:  Afr Health Sci       Date:  2010-09       Impact factor: 0.927

6.  Antihyperglycemic effects of separate and composite extract of root of Musa paradisiaca and leaf of Coccinia indica in streptozotocin-induced diabetic male albino rat.

Authors:  Chhanda Mallick; Kausik Chatterjee; Mehuli Guhabiswas; Debidas Ghosh
Journal:  Afr J Tradit Complement Altern Med       Date:  2007-02-16

7.  Insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cells.

Authors:  Cui Hao; Jiejie Hao; Wei Wang; Zhangrun Han; Guangsheng Li; Lijuan Zhang; Xia Zhao; Guangli Yu
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

8.  The antidiabetic effects of a dry powder of dietary vegetable and fruit mixtures in diabetic db/db mice.

Authors:  Chung-Man Yeung; Yi Tan; Sidney Tam; Liwei Lu; King-Hung Ko; Pai-Hao Yang; Hsiang-Fu Kung; Marie C Lin
Journal:  Biologics       Date:  2008-09

9.  Levan from Bacillus subtilis Natto: its effects in normal and in streptozotocin-diabetic rats.

Authors:  Fernando Cesar Bazani Cabral de Melo; Cássia Thaïs Bussamra Viera Zaia; Maria Antonia Pedrine Colabone Celligoi
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study.

Authors:  Chung-Yu Huang; Yueh-Ting Tsai; Jung-Nien Lai; Feng-Lin Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.